Evidence map›Paper›PMID 35451955›Full record

ArticleeLife2022

A functional screen of RNA binding proteins identifies genes that promote or limit the accumulation of CD138+ plasma cells.

David J Turner, Alexander Saveliev, Fiamma Salerno, Louise S Matheson, Michael Screen, Hannah Lawson, David Wotherspoon, Kamil R Kranc, Martin Turner

Open access · goldAbstract read
In one paragraph

Article in eLife, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Posttranscriptional control of the B cell receptor by HuR is essential for innate B cell maintenance and function.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  10. mJournal for immunotherapy of cancer · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

David J TurnerImmunology Programme, The Babraham Institute,Babraham Research Campus, Cambridge, United Kingdom.ORCID 0000-0003-4379-6152
Alexander SavelievImmunology Programme, The Babraham Institute,Babraham Research Campus, Cambridge, United Kingdom.
Fiamma SalernoImmunology Programme, The Babraham Institute,Babraham Research Campus, Cambridge, United Kingdom.
Louise S MathesonImmunology Programme, The Babraham Institute,Babraham Research Campus, Cambridge, United Kingdom.
Michael ScreenImmunology Programme, The Babraham Institute,Babraham Research Campus, Cambridge, United Kingdom.
Hannah LawsonLaboratory of Haematopoietic Stem Cell and Leukaemia Biology, Queen Mary University of London, London, United Kingdom.
David WotherspoonLaboratory of Haematopoietic Stem Cell and Leukaemia Biology, Queen Mary University of London, London, United Kingdom.
Kamil R KrancLaboratory of Haematopoietic Stem Cell and Leukaemia Biology, Queen Mary University of London, London, United Kingdom.
Martin TurnerImmunology Programme, The Babraham Institute,Babraham Research Campus, Cambridge, United Kingdom.ORCID 0000-0002-3801-9896
Babraham Institute · GBQueen Mary University of London · GB

Funding

Biotechnology and Biological Sciences Research Council BB/L016745/1Biotechnology and Biological Sciences Research Council BBS/E/B/000C0427Biotechnology and Biological Sciences Research Council BBS/E/B/000C0428Cancer Research UK 14633Cancer Research UK 26787Cancer Research UK C29967/A26787Medical Research Council MR/P010008/1Medical Research Council MR/P010008/2Wellcome Trust 200823/Z/16/Z
6 · The paper itself

Abstract

To identify roles of RNA binding proteins (RBPs) in the differentiation or survival of antibody secreting plasma cells we performed a CRISPR/Cas9 knockout screen of 1213 mouse RBPs for their ability to affect proliferation and/or survival, and the abundance of differentiated CD138 + cells in vitro. We validated the binding partners CSDE1 and STRAP as well as the m

Indexed as

Plasma CellsRNA-Binding ProteinsAnimalsCarrier ProteinsMiceCarrier ProteinsRNA-Binding Proteinsantibody secreting cellB celldevelopmental biologyimmunologyinflammationmouseRNA binding protein

Identifiers

PMID35451955
PMCPMC9106329
OpenAlexW4224224561

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.